Login / Signup

Timing of sodium-glucose cotransporter 2 inhibitor initiation and post-discharge outcomes in acute heart failure with diabetes: A population-based cohort study.

Che-Yuan WuBaiju R ShahAbhinav SharmaYiru ShengPeter P LiuAlexander KoppRefik SaskinJodi D EdwardsWalter Swardfager
Published in: European journal of heart failure (2024)
Real-world evidence supports early SGLT2 inhibitor initiation to reduce HHF or cardiovascular mortality in acute heart failure and type 2 diabetes.
Keyphrases
  • acute heart failure
  • type diabetes
  • heart failure
  • glycemic control
  • cardiovascular disease
  • insulin resistance
  • risk factors
  • skeletal muscle